Flexion Therapeutics Announces Publication of New Abstracts Accepted at Osteoarthritis Research Society International OARSI 2020GlobeNewsWire • 05/01/20
Flexion Therapeutics Announces Positive Preclinical Data Supporting Development of FX301, a Locally Administered Nav1.7 Inhibitor Product Candidate for Post-Operative PainGlobeNewsWire • 04/27/20
Flexion Therapeutics Announces ZILRETTA® License Agreement and Provides Business Update Amid Coronavirus PandemicGlobeNewsWire • 04/01/20
Flexion Therapeutics: Reporting Record Revenue On A Record Day For The MarketSeeking Alpha • 03/19/20
Flexion Therapeutics, Inc. (FLXN) CEO Mike Clayman on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/13/20
Flexion Therapeutics (FLXN) Reports Q4 Loss, Tops Revenue EstimatesZacks Investment Research • 03/12/20
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire • 03/06/20
Will Flexion Therapeutics (FLXN) Report Negative Earnings Next Week? What You Should KnowZacks Investment Research • 03/05/20
Flexion Therapeutics (FLXN) May Report Negative Earnings: Know the Trend Ahead of Q4 ReleaseZacks Investment Research • 02/20/20
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire • 02/07/20
Flexion Therapeutics Announces Preliminary, Unaudited Fourth-Quarter and Full-Year 2019 Revenue and Initial Revenue Guidance for 2020GlobeNewsWire • 01/09/20
Flexion Therapeutics (FLXN) Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire • 01/03/20
Is the Options Market Predicting a Spike in Flexion (FLXN) Stock?Zacks Investment Research • 12/31/19
Flexion Therapeutics stock soars 24% premarket as FDA approves label change for OA keen pain therapyMarket Watch • 12/27/19
Flexion Therapeutics Announces FDA Approval of sNDA to Revise ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) Product LabelGlobeNewsWire • 12/26/19
Flexion Therapeutics Enrolls First Patients in Phase 2 Trial of ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) in OA of the Shoulder and Adhesive CapsulitisGlobeNewsWire • 12/17/19